National Cancer Institute confirmed, approved a grant of $ 11 million, in 2010 - the largest amount of money granted - not scientific or commercial reviews.
In cancer prevention and the Texas Institute of disclosure after a tumultuous summer, it has revoked a $ 20 million grant to a group led by the University of Texas MD Anderson Cancer Center, because the integrity of the review process.
Awarded in 2010, recruitment, migration and the formation of the biotechnology company, headquartered in Dallas, riders treatment. "Riders to the discovery and development of new anti-cancer drugs. Grant the grant of the first four commercial organizations.
Cancer Institute, the internal audit found that its main business personnel when Jerry Cobbs, incorrect riders commercialization awards Oversight Committee recommended list. Although it is not commercial or scientific review panel reviewed riders granted approval.
Cobbs month resignation undisclosed reasons. He was unable to comment on the matter Thursday.
"CPRIT must have the trust of our fellow Texans, we not only do a great job, but we also do everything the right way," Bill Gimson, executive director, said in a statement released on Thursday night.
Recalling skip
Although the argument seems to blame Cabos, said the agency's Web site, which is the executive director of Gimson work submitted to the Oversight Committee ultimately approved list of applications granted share options. It says the commercialization of the Vetting Committee recommendations, the executive director.
The officials refused to disclose how many grants have been distributed to a large force. The founder of the company, the University of Texas Southwestern biochemist 史蒂芬麦克 Knight did not respond to requests for comment.
Large forces press conference, announced the grant in July 2010, Cobbs was quoted as saying the relationship between The award marks the national institutions and companies is just the beginning.
: "CPRIT very pleased to provide significant value in the development of breakthrough cancer treatment, cancer patients and their families, and their potential to contribute to the success of" Cobbs said. "We anticipate a long and fruitful relationship."
The agency said that the riders have been re-submitted its recommendations to the commercialization and scientific review.
Voters approved the establishment of the cancer initiative $ three hundred million taxpayer-funded bonds issued in 2007, State agencies and enterprises to 10 years of cancer research and treatment. It's the first grant was awarded in late 2009.
Collective resignation
Summer and autumn institutions, to meet the scientific review led by the Nobel laureate in economics, aluminum Gilman resign. Scientists cry foul over 20 million U.S. dollars in grants awarded to Dr researcher at the University of Texas MD Anderson Cancer Center is a research team led by Dr. Ronald DePinho, president of the agency's wife Linda Exhibition anticancer drugs commercialization.
Resignation scientists cited concern about the cancer initiative of some members of the political appointees of the Oversight Committee, especially biotechnology Houston investor Charles Tate, use undue influence to ensure that certain business grant funds, rather than a scientific review.
Tate is still a member of the oversight committee of the institution.
The cancer organizations the MD Anderson granted controversy, has vowed to reform the process through business subsidies gold. Also hired a compliance officer the Patricia Vojack, add another layer of oversight.
Its actions are expected to review and the National Audit Office will make recommendations to the Legislative Council in 2013, the relevant agencies in January.
Prior to this, the the latest whistleblowers State governor Rick Perry said, support for CPRIT, said in October, the chairman of the board, the telecommunications company manager James Mansour, has done a "special".
Criticism expressed
External observers have been charitable, however. Influential scientific journal "Nature" called for the resignation, due to the the CPRIT obvious "cronyism" Mansour.
And an independent ethicists, said Paul Wolpe of Emory University, which is hard to imagine that the body can maintain its credibility unless Mansour and other leaders to step down. "I see here is damage control, rather than responsibility, deafness, rather than sensitivity," Volpe said in October.
No comments:
Post a Comment